Abstract Acute kidney injury (AKI) is a potential complication following cardiopulmonary bypass (CPB) surgery in infants and young children with congenital heart disease (CHD). The current pilot study evaluates the predictive value of serum cystatin C (CysC) for AKI after pediatric CPB surgery. We prospectively enrolled 43 children with CHD (30 males and 13 females) who underwent CPB surgery. They were aged 3 years or younger. Serum CysC was measured at baseline and at 6 hours, 12 hours, 24 hours, and 48 hours after initiating CBP. Twenty-one (48.8%) patients developed AKI after cardiac surgery. Children who developed AKI had more complex cardiac surgical procedures (based on the Risk Adjustment for Congenital Heart Surgery 1 [RACHS-1] category), a longer CPB duration, and a longer aortic clamping time (ACT). Serum concentrations of CysC postoperatively demonstrated an initial decline at 6 hours, a subsequent increase at 12 hours, and stabilized at 24e48 hours. The best predictive performance was achieved 6 hours after CPB with an area under receiver operating characteristic curve (AUC) value of 0.69. The optimal cut-off value was 0.47 mg/L (sensitivity, 85.7%; specificity, 50%). By contrast, the RACHS-1 category, CPB duration, and ACT had higher AUC values at 0.735, 0.791, and 0.731, respectively. In conclusion, serum CysC had limited predictive capacity and was not superior to clinical risk factors for the early detection of AKI after CPB surgery in this pilot study, which focused on infants and young children.
Introduction
In children with congenital heart disease (CHD), renal injury is a potential complication following cardiopulmonary bypass (CPB) surgery [1, 2] . The spectrum ranges from subclinical injury to acute renal failure (ARF) that requires peritoneal dialysis (PD). Despite substantial improvements in surgical techniques and perioperative management, ARF-associated morbidity and mortality remain high. According to a recent summary, ARF affects 1.6e32.8% of pediatric patients and has mortality rates of 20e79% [3] . The Acute Kidney Injury Network (AKIN) recently supported the use of the term "acute kidney injury" (AKI) to denote the entire spectrum of acute renal injuries, including ARF [4] .
The current AKI diagnostic criteria are based on changes in the serum creatinine level and clinical oliguria [4] . However, the serum creatinine level is not an early indicator during acute changes in renal function. Its concentration fails to increase until 50% of kidney function has already been lost [5] , and it does not accurately depict renal function until a steady state equilibrium has been reached, which can take several days after the initial insult. Therefore, the elevation of serum creatinine lags behind renal injury and decline of renal function. The AKIN adopted a 48-hour window for a creatinine-based definition. Previous studies have shown that AKI and ARF can be prevented and/or treated by several maneuvers such as renal replacement therapy, but these maneuvers must be instituted very early after the initial insult and well before the serum creatinine level begins to rise [6] . The diagnosis unfortunately is often delayed; therefore, the quest for improving the early diagnosis of AKI is an area of intense research.
Cystatin C (CysC) is a cysteine protease inhibitor that is synthesized and released into the blood at a relatively constant rate by all nucleated cells. It is freely filtered by the glomerulus, completely reabsorbed and metabolized by the proximal tubules, and is not secreted. These inherent properties make serum CysC an attractive and promising biomarker for assessing renal glomerular function, compared to serum creatinine. Measuring the serum CysC level may provide new insight into the early diagnosis of AKI. Recent studies show that in many clinical settings serum CysC has diagnostic value when measured early (e.g., within 24 hours after the renal insult or after intensive care unit admission) [7, 8] . It is also superior to conventional biomarkers in predicting AKI soon after adult cardiac surgery [9] . However, the performance of serum CysC as a biomarker has been less frequently studied in infants and young children in whom the risk of postoperative ARF is high. The aim of this pilot study was to investigate the predictive value of serum CysC for AKI after CPB surgery in the very young population.
Design and methods

Study population
During a 6-month period, we prospectively enrolled all children with CHD, aged 3 years or less, who underwent CPB surgery at Beijing Anzhen Hospital. The exclusion criteria were congenital abnormality of the urological system, severe liver dysfunction, primary blood disease, malignant tumor, and use of nephrotoxic drugs before admission and during the study period. Based on whether AKI developed after surgery, the subjects were divided into the AKI group and non-AKI group. According to the AKIN criteria and other studies that involved children, AKI was defined as an acute decline in renal function within 72 hours of surgery; an absolute increase in serum creatinine level of 0.3 mg/dL (26.4 mmol/L) or greater; a 50% or greater percent increase in serum creatinine; or reduced urine output of less than 0.5 mL/kg per hour for more than 6 hours [4] . Because of the possibility of hemodilution associated with CPB and the delayed increase in the serum creatinine level needed to achieve the AKIN criteria, we adopted a 72-hour period, which has often been used in other pediatric studies, instead of 48 hours.
Sample collection and measurement of serum CysC
We collected blood samples at baseline, and at 6 hours, 12 hours, 24 hours and 48 hours after initiating CBP. The samples were centrifuged at 2000 Â g for 10 minutes and the serum supernatants were stored at e80 C. By using a commercially available kit for human CysC (N latex CysC Kit; Dade Behring, Marburg, Germany) and BN II system (Siemens Healthcare Diagnostics, Deerfield, IL), the serum CysC concentrations were measured at the clinical laboratory of Peking University First Hospital by a particleenhanced nephelometric immunoassay. The lower limit of detection for CysC was 0.05 mg/L. The intra-assay and interassay coefficients of variation were below 2.5% and 5%, respectively. The serum creatinine level was measured routinely at baseline and twice daily during the first three postoperative days and once daily thereafter. The parents or legal guardian of each child provided written, informed consent.
Statistical analysis
Statistics analysis was performed by using SPSS version 13.0 (SPSS, Chicago, IL). Normally distributed variables were expressed as the mean AE SD, whereas non-normally distributed variables were expressed as the median (i.e., interquartile range). Continuous variables were compared by using the two independent samples t test or the rank sum test. Categorical variables were displayed as a percentage and compared by using the c 2 test or Fisher exact test. The receiver operating characteristic (ROC) curve was generated. The area under the ROC curve (AUC) was measured to evaluate the predictive performance of the serum CysC level for AKI. An AUC value of 1.0 signified a perfect biomarker, and a value of 0.5 signified it was no better than what would be expected by chance. The optimal cut-off value was the value that had the highest combined sensitivity and specificity. A twosided p value of < 0.05 was considered statistically significant.
Results
Clinical information
Sixty children were initially considered for participation in the study, and 43 children (30 males and 13 females) met the inclusion criteria and constituted the study cohort. Table 2) , longer CPB and aortic clamping times (ACT), and worse clinical outcomes. Urine output during the first 24 hours after surgery did not differ between the two groups. In the AKI group, one child developed ARF requiring PD and two patients died. The hospital stay in the intensive care unit (ICU) was longer in the AKI group than in the non-AKI group. Table 3 shows the measurements of the serum CysC level at baseline and at the various timepoints after CPB surgery. The baseline concentrations were comparable between the two groups. In both groups, the serum CysC concentrations showed an initial decline at 6 hours, but had increased by 12 hours, and stabilized at 24e48 hours postoperatively. In the AKI group, the serum CysC concentration approached baseline levels 24e48 hours after surgery. By contrast, the serum CysC concentration in the non-AKI group remained lower at 48 hours than at baseline. Table 3 and Fig. 1 illustrate the ROC analysis of serum CysC for predicting AKI. The best predictive performance was achieved 6 hours after CPB with an AUC value of 0.69. The optimal cut-off value at 6 hours was 0.47 mg/L (sensitivity, 85.7%; specificity, 50%; positive predictive value, 62.1%; and negative predictive value, 78.6%). By contrast, RACHS-1 category, CPB duration, and ACT had higher AUC values of 0.735, 0.791, and 0.731, respectively.
Serial measurements of serum CysC
ROC analysis of serum CysC for predicting AKI
Discussion
The incidence of AKI in infants and young children after congenital heart surgery was high in this pilot study. Clinical risk factors included a high RACHS-1 category, prolonged CPB time, and prolonged ACT. The consensus-based algorithm, RACHS-1, is based on in-hospital mortality of children after congenital heart surgery; higher RACHS-1 categories portend a higher mortality [10] . In this small cohort, all children were assigned to categories 2 to 4. Category 1 included simple cardiac defects (such as isolated atrial septal defect) and partially anomalous pulmonary venous connection. Patients in this category rarely underwent CPB surgery at a very young age. Cardiac surgical procedures in categories 5 and 6 were highly complex and rarely performed in our center. No category 5 or 6 patients were admitted during the study period.
In recent years, the early diagnosis of AKI by using kidney-specific biomarkers has become a field of intensive study and could facilitate early intervention in high-risk individuals. Serum CysC is a theoretically ideal and promising index of glomerular function, compared to serum creatinine. A prominent advantage of measuring serum creatinine is that a standardized immunonephelometric assay is available that is automated and provides results in minutes. In addition, routine clinical storage conditions, freeze/thaw cycles, and the presence of interfering substances do not seem to affect its measurement. Serum CysC is currently being investigated and validated for its ability to predict AKI under different clinical circumstances. In critical care settings, serum CysC predicted AKI 1 to 2 days earlier than serum creatinine [8] . Preoperative serum CysC provides a better assessment of the risk of death and AKI following cardiac surgery, compared to serum creatinine [11, 12] . In this pilot study, serum CysC concentrations demonstrated an initial decline after CPB and remained lower than the baseline levels up to 48 hours after surgery in many patients. This may be attributed to hemodilution associated with CPB. This effect could be more prominent in infants and young children because of their lower body weight and blood volume. In ROC analysis, serum CysC showed a limited ability to predict AKI after pediatric heart surgery. Its predictive values (AUC, 0.56e0.69) were much lower than the predictive values of clinical risk factors such as the RACHS-1 category, CPB duration, and ACT. This finding was consistent with the results of recent studies on adult CPB surgery [13e15]. In a study conducted by Wald et al. [14] , the plasma CysC concentration also demonstrated an initial decline after CPB and was higher at all timepoints in patients who developed AKI than in patients who did not develop AKI. The discriminatory capacity of plasma CysC measured preoperatively (AUC, 0.57) and at 2 hours after the conclusion of CPB (AUC, 0.61) was modest [14] . Koyner et al. [15] also suggested plasma CysC, with an AUC value of 0.62 at 2 hours postoperatively, was not an early predictor of AKI after adult cardiac surgery. In elderly patients undergoing cardiac surgery, serum CysC was not superior to plasma creatinine for the early detection of postoperative AKI [13] . In these studies, the initial decline of the serum CysC concentration seemed to limit its capacity for AKI prediction soon after cardiac surgery. The pathogenesis of CPB-related AKI was renal tubular injury, which is mediated by ischemiaereperfusion injury, inflammatory reaction, and microembolism [16] . However, serum CysC is a well-known index of glomerular function. The delay from tubular injury to subsequent glomerular dysfunction may explain the limited performance of serum CysC as an early predictor of AKI.
However, several other studies suggest that serum CysC could serve as an early predictive biomarker for AKI after pediatric and adult CPB surgery [9, 17] . In patients who developed postoperative AKI, the serum CysC level increased substantially within the first 12 hours following CPB; the CysC level had good predictive values at 12e24 h (AUC, 0.81e0.91) [9, 17] . The reason for the divergent results among the studies is unclear. The discrepancy in the postoperative changing patterns of serum CysC may be related to different strategies used among the centers in fluid management in the operating room. However, these data are rarely reported in the literature. Future studies are required that evaluate the effect of CPB fluid management on the predictive capacity of serum CysC.
The serum concentration of CysC is not significantly influenced by nonrenal factors that affect the serum creatinine concentration. However, cardiac function is clearly associated with renal dysfunction and thus serum CysC levels. Cardiac injury and dysfunction are other wellrecognized potential complications associated with CPB surgery. Aside from direct renal injury from CPB insult, impaired cardiac function and low cardiac output could cause persistent renal hypoperfusion and further aggravate renal injury after surgery. Postoperative fluid management may also play an important role in AKI and its clinical outcome. Adequate hydration and the use of inotropic and diuretic agents to avoid volume depletion and support cardiac function could maintain effective renal perfusion and prevent the further progression of AKI [18] . Thus, the state of postoperative cardiac function and perioperative management could affect postoperative serum CysC concentrations and should be considered when trying to explain the discrepancy among studies.
The major limitation of our study is the small sample volume. Only one child (4.8%) developed ARF and required PD. The predictive capacity of serum CysC for ARF cannot be inferred from the preliminary results of this pilot study and must be further determined in future large-scale studies.
In summary, in this pilot study, the serum CysC concentration had limited predictive capacity and was not superior to clinical risk factors for the early detection of AKI after CPB surgery in infants and in young children. Figure 1 . The receiver operating characteristic analysis of serum cystatin C for the prediction of AKI at 6 h after CPB.
